- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Pwynt Penodol mewn Amser (25/05/2023)
- Gwreiddiol (a wnaed Fel)
The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 is up to date with all changes known to be in force on or before 17 August 2024. There are changes that may be brought into force at a future date.
Changes and effects yet to be applied by the editorial team are only applicable when viewing the latest version or prospective version of legislation. They are therefore not accessible when viewing legislation as at a specific point in time. To view the ‘Changes to Legislation’ information for this provision return to the latest version view using the options provided in the ‘What Version’ box above.
PART 3 General matters relating to pharmaceutical lists and applications in respect of them
12.Routine applications for inclusion in or amendments to a pharmaceutical list
13.Current needs: additional matters to which the NHSCB must have regard
15.Future needs: additional matters to which the NHSCB must have regard
17.Improvements or better access to the current service: additional matters to which the NHSCB must have regard
18.Unforeseen benefits applications: additional matters to which the NHSCB must have regard
19.Applications to which regulation 17 or 18 applies: consequences of additional matters
20.Future improvements or better access: additional matters to which the NHSCB must have regard
21.Future improvements or better access: consequences of additional matters
21A.PNA based applications for new premises offering additional or different opening hours
22.Refusal of routine applications that are based on neither a pharmaceutical needs assessment nor unforeseen benefits
23.Applications from NHS chemists in respect of providing directed services
24.Relocations that do not result in significant change to pharmaceutical services provision
27.Applications for temporary listings arising out of suspensions
28.Applications from persons exercising a right of return to a pharmaceutical list
29.Temporary arrangements during emergencies or because of circumstances beyond the control of NHS chemists
33.Refusal of applications for inclusion in a pharmaceutical list on fitness grounds
34.Deferral of consideration of applications for inclusion in a pharmaceutical list on fitness grounds
35.Granting applications for inclusion in a pharmaceutical list subject to efficiency conditions and conditions to combat fraud
PART 7 Areas that are controlled localities or reserved locations, and new pharmacies within them
37.Process for determining controlled localities: preliminary matters
38.Process for determining controlled localities: local notification and deferment of routine applications
39.Process of determining controlled localities: formulation of the NHSCB's decision
40.Applications for new pharmacy premises in controlled localities: refusals because of preliminary matters
41.Applications for new pharmacy premises in controlled localities: reserved locations
42.Second and subsequent determinations of reserved location status
43.Determinations of reserved locations: supplemental matters
44.Prejudice test in respect of routine applications for new pharmacy premises in a part of a controlled locality that is not a reserved location
48.Arrangements for the provision of pharmaceutical services by doctors: applications by patients
50.Discontinuation of arrangements for the provision of pharmaceutical services by doctors
51.Outline consent and premises approval: applications by doctors
52.Notification of applications for outline consent and premises approval
53.Decisions on outline consent and premises approval applications and the taking effect of grants
54.Premises approval: relocations of practice premises which are not significant before outline consent takes effect
55.Premises approval: relocations of practice premises which are not significant after outline consent has taken effect
56.Taking effect of premises approval where there is no related application for outline consent
58.Temporary provision in cases of relocations or additional premises where premises approval has not taken effect
61.Temporary arrangements during emergencies or circumstances beyond the control of a dispensing doctor
62.Persons barred from taking part in decision making with regard to applications for outline consent or premises approval
PART 10 Performance related sanctions and market exit
69.Local dispute resolution before serving remedial notices or breach notices
71A.Issuing breach or remedial notices while a disease is or in anticipation of a disease being imminently pandemic etc.
73.Removal of listings: cases relating to remedial notices and breach notices
74.Removal of listings: cases relating to death, incapacity or cessation of service
75.Voluntary and automatic removal of listings: change of ownership, relocation, temporary provision and voluntary closure
76.Limitation on withdrawal from pharmaceutical lists while fitness investigations or proceedings are ongoing
PART 11 Enforcement, reviews and appeals relating to fitness matters
79.Review of decisions to impose fitness conditions originally imposed on grants of applications
80.Removal for breach of fitness conditions imposed under regulation 35 or 79
82.Fitness cases: procedures for removal or contingent removal from pharmaceutical lists
84.Procedure for reviewing some suspensions and contingent removal conditions
85.General power to revoke suspensions in appropriate circumstances
86.Internal handling of fitness information by the NHSCB or an agent of the NHSCB
PART 13 Local Pharmaceutical Services
99.Designation of areas, premises or descriptions of premises
102A.Suspension of terms of schemes or of enforcement of terms of schemes while a disease is or in anticipation of a disease being imminently pandemic etc.
105.Persons permitted to be parties to LPS schemes: fitness criteria
108.Right of return to pharmaceutical lists: LPS contractors
111.Emergencies requiring the flexible provision of local pharmaceutical services
112.Sharing of information about LPS chemists and their employees with the General Pharmaceutical Council
113.Directions to the First-tier Tribunal relating to local pharmaceutical services
Information to be contained in pharmaceutical needs assessments
Applications in respect of pharmaceutical lists and the procedures to be followed
PART 1 Information to be included in routine and excepted applications
1.Information to be included in all routine and excepted applications
2.Information to be included in all routine and excepted applications for inclusion in a pharmaceutical list
3.Fitness information about individuals: routine and excepted applications for inclusion in a pharmaceutical list
4.Fitness information about corporate bodies: routine and excepted applications for inclusion in a pharmaceutical list
5.Fitness information that has already been provided under pharmaceutical or local pharmaceutical services
5A.Updating of information about or relating to a superintendent
6.Applications seeking the listing of premises that are already, or are in close proximity to, listed chemist premises
7.Additional information to be included with routine applications
8.Additional information to be included with excepted applications
13.Functions of the NHSCB in relation to fitness information relevant to applications: aggregation of information
14.Deferral of notifiable applications prior to notification
15.Refusal of notifiable applications prior to notification because of the language requirement for some NHS pharmacists
16.Refusal of notifiable applications on fitness grounds prior to notification
17.Proposed new pharmacy premises in controlled localities: refusal of routine applications because of preliminary matters prior to notification
PART 5 Notification, taking effect of decisions and rights of appeal to the Secretary of State
28.Notification of decisions on routine and excepted applications
29.Template notice of commencement to be included with a notice of decision
30.Third party rights of appeal to the Secretary of State where an application is granted
31.Conditional grant of applications where the address of the premises is unknown
32.Changes to the premises specified in an application after its grant but before the listing of the premises
33.Conditional grant in cases relating to future needs or future improvements or better access
34A.Taking effect of decisions relating to business consolidations
35.Notice requiring the commencement of pharmaceutical services
Appeals to the Secretary of State
PART 2 Notification of appeals
3.Notification of appeals notices under paragraph 30, 32(5) or 36 of Schedule 2
4.Notification of appeals relating to notices under regulation 45
5.Notification of appeals relating to decisions under Part 8 of these Regulations
6.Non notification of appeals relating to notices under regulation 77 or 98
Terms of service of NHS pharmacists
7.Preliminary matters before providing ordered drugs or appliances
10.Further activities to be carried out in connection with the provision of dispensing services
11.Additional requirements in relation to electronic prescribing
12.Additional requirements in relation to specified appliances
15.Further activities to be carried out in connection with the disposal of unwanted drugs
22A.Home delivery service while a disease is or in anticipation of a disease being imminently pandemic etc.
22AA.Home delivery of notified items while a disease is or in anticipation of a disease being imminently pandemic etc.
22C.Service outline in respect of the discharge medicines service
24.Matters to be considered when issuing directions in respect of pharmacy premises core opening hours
25.Determination of pharmacy premises core opening hours instigated by the NHSCB
26.Determination of pharmacy premises core opening hours instigated by the NHS pharmacist
27.Temporary opening hours and closures during an emergency requiring the flexible provision of pharmaceutical services
27A.Pharmacy opening hours: arrangements while a disease is or in anticipation of a disease being imminently pandemic etc.
27B.Flexible provision of relevant immunisation services during a pandemic etc.
28B.Consultations held from distance selling premises and some small pharmacy premises
28C.Distance selling premises requirements in respect of websites and health promotion zones
29C.Contact via NHSmail, pharmacy profiles and the Central Alerting System
31.Duty to provide information about fitness matters as they arise
Terms of service of NHS appliance contractors
1.Division of responsibilities between individuals and corporate bodies
9.Further activities to be carried out in connection with the provision of dispensing services
10.Additional requirements in relation to electronic prescribing
11.Additional requirements in relation to specified appliances
14.Matters to be considered when issuing directions in respect of core opening hours
15.Determination of core opening hours instigated by the NHSCB
16.Determination of core opening hours instigated by the NHS appliance contractor
17.Temporary open hours and closures during an emergency requiring the flexible provision of pharmaceutical services
21.Duty to provide information about fitness matters as they arise
Terms of service of dispensing doctors
1.Persons duly authorised to dispense on behalf of dispensing doctors
2.Dispensing of drugs and appliances ordered by another prescriber
3.Dispensing of drugs and appliances ordered by the dispensing doctor
4.Preliminary matters before providing ordered drugs or appliances
4A.Charge exemption and remission of charges: declarations and checks
4B.Checks and records in the case of supply in accordance with a SSP
7.Dispensing doctors issuing prescription forms which may be presented to an NHS chemist
7A.Home delivery service while a disease is or in anticipation of a disease being imminently pandemic etc.
7AA.Home delivery of notified items while a disease is or in anticipation of a disease being imminently pandemic etc.
Mandatory terms for LPS schemes
5.Preliminary matters before providing ordered drugs or appliances
8.Further activities to be carried out in connection with the provision of dispensing services
9.Additional requirements in relation to electronic prescribing
10A.Home delivery service while a disease is or in anticipation of a disease being imminently pandemic etc.
10AA.Home delivery of notified items while a disease is or in anticipation of a disease being imminently pandemic etc.
15.Duty to provide information about fitness to practise matters as they arise
17.Charges for drugs, appliances and containers, and ownership of containers
29.Termination of arrangements by the NHSCB on grounds of suitability etc
30.Termination by the NHSCB: patient safety and material financial loss
2.Listing applications under the 2005 Regulations: NHS chemists
3.Listing applications under the 2012 Regulations: NHS chemists
4.Listing applications under the 2005 Regulations: dispensing doctors
5.Listing applications under the 2012 Regulations: dispensing doctors
9.Gradual discontinuation of the provision of pharmaceutical services by doctors
10.Gradual introduction of the provision of pharmaceutical services by doctors
11.Giving effect to listing decisions: pharmaceutical lists and dispensing doctor lists
12.Pharmaceutical lists, EPS lists and dispensing doctor lists: continuity of entries and decisions
15.LPS schemes: replacement of Primary Care Trusts with the NHSCB and service provision issues
16.Notification of LPS designations and completion of reviews
17.The application of Group 12 of Schedule 8 to the Value Added Tax Act 1994
1.Amendment of the National Health Service (Charges for Drugs and Appliances) Regulations 2000
2.Revocation of the National Health Service (Local Pharmaceutical Services and Pharmaceutical Services) Regulations 2002
3.Revocation of the National Health Service (Local Pharmaceutical Services and Pharmaceutical Services) (No. 2) Regulations 2002
4.Revocation of the National Health Service (Pharmaceutical Services) Amendment Regulations 2005
5.Revocation of the National Health Service (Local Pharmaceutical Services etc.) Regulations 2006 and amendments to those Regulations
6.Revocation of the National Health Service (Pharmaceutical Services) (Amendment) Regulations 2006
7.Amendments to the Local Authority Social Services and National Health Service Complaints (England) Regulations 2009
8.Revocation of the National Health Service (Pharmaceutical Services and Local Pharmaceutical Services) Amendment Regulations 2009
9.Revocation of the National Health Service (Pharmaceutical Services and Local Pharmaceutical Services) (Amendment) Regulations 2010
10.Revocation of the National Health Service (Local Pharmaceutical Services) Amendment Regulations 2012
11.Revocation of the National Health Service (Pharmaceutical Services) Regulations 2012 and of amendments to those Regulations
12.Amendment of the Local Authorities (Partnership Arrangements, Care Trusts, Public Health and Local Healthwatch Arrangements etc.) Regulations 2012
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
Yr Offeryn Cyfan you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Y Rhestrau you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.
Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Mae Memoranda Esboniadol yn nodi datganiad byr o ddiben Offeryn Statudol ac yn rhoi gwybodaeth am ei amcan polisi a goblygiadau polisi. Maent yn ceisio gwneud yr Offeryn Statudol yn hygyrch i ddarllenwyr nad oes ganddynt gymhwyster cyfreithiol, ac maent yn cyd-fynd ag unrhyw Offeryn Statudol neu Offeryn Statudol Drafft a gyflwynwyd ger bron y Senedd o Fehefin 2004 ymlaen.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys